Form 4: Anixa Biosciences CFO Buys Shares
Insider Transaction (Form 4)
Michael Catelani, President, COO, & CFO of Anixa Biosciences Inc, purchased 5,500 shares of common stock on September 30, 2026 for $2.84 per share.
Summary
- Open-market purchase: acquired 5,500 Common Stock at $2.84 ($15,620) on September 30, 2026; holds 50,000 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $15,620, committing personal capital to the stock.
Insider Transactions
Michael Catelani — Officer (President, COO, & CFO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-30 | Open-market purchase | Common Stock | 5,500 | $3 | $15.6K | 50,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-30 | Open-market purchase (5,500 shares) |
Keywords
insider transaction, Form 4, ANIX, Anixa Biosciences Inc, bullish, Michael Catelani
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.